ReviewPediatric dermatology2025
Epidemiology of Pediatric Alopecia Areata.
Review in Pediatric dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Role ofJID innovations : skin science from molecules to population health · 2026Article
- Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040.Clinical, cosmetic and investigational dermatology · 2026Article
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review.Journal of clinical medicine · 2025Review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology.Frontiers in immunology · 2025Review
- Burden of immune-related skin diseases worldwide, 1991-2021: insights and prediction from the Global Burden of Disease Study.Frontiers in immunology · 2025Article
- Correction to "Epidemiology of Pediatric Alopecia Areata".Pediatric dermatologyArticle
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This contemporary scoping narrative review examines the epidemiology of pediatric alopecia areata (AA), focusing on incidence, prevalence, racial and ethnic differences, and comorbidities. Articles containing original epidemiology on pediatric AA published between 2013 and 2024 were identified. From these studies, the estimated US child and adolescent incidence of AA is between 13.6 and 33.5 per 100,000 person-years, and the prevalence of AA is between 0.04% and 0.11%. Incidence and prevalence rates vary widely by geographic region and nation. A general pattern of highest estimated lifetime prevalence in North African and Middle Eastern nations, followed by high-income North American countries, then by Asian and Western European nations, and, lastly, by Latin America and sub-Saharan Africa emerged. Though infrequently reported, racial and ethnic differences were noted in the largest pediatric-specific studies: Hispanic/Latino, Black, and Asian children were affected by AA at higher rates compared to those who self-identify as White/Caucasian. AA carried a high burden of comorbidities, including atopic disease, vitiligo, mental illness, and thyroid conditions. The existing pediatric epidemiology can help identify potential disparities in care and guide additional research, advocacy, and policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.